IRIDEX Corporation

IRIX ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2016 FY2015 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-11.7M $10.0M $2.2M $1.4M $2.6M $2.6M
Depreciation & Amortization $648.0K $420.0K $490.0K $427.0K $410.0K $440.0K
Depreciation $632.0K $376.0K $264.0K $236.0K $185.0K —
Amortization $16.0K $44.0K $226.0K $191.0K $196.0K —
Stock-Based Compensation — $972.0K $689.0K $388.0K $478.0K $271.0K
Net Cash from Operating Activities $-144.0K $4.0M $767.0K $-1.1M $2.3M $3.0M
Investing Activities
Capital Expenditures $1.1M $568.0K $380.0K $394.0K $203.0K $190.0K
Business Acquisitions — — — $0 $75.0K $0
Net Cash from Investing Activities $-1.3M $-1.0M $-763.0K $-722.0K $-278.0K $-190.0K
Financing Activities
Dividends Paid — — — — — —
Stock Repurchases $59.0K $4.7M $426.0K $2.8M $648.0K $0
Net Cash from Financing Activities $-1.4M $-3.1M $1.0M $-2.4M $-327.0K $-1.7M
Net Change in Cash $13.8M $-141.0K $1.5M $1.1M $2.4M $3.9M
Free Cash Flow $-1.2M $3.4M $387.0K $-1.5M $2.0M $2.8M
← Newer Page 2 of 2 Older →